COCHLEAR FPO [COH] (COH.AX) Financials
COH.AX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 2.5 billion | 748.7 million |
2023-06-30 | 2.6 billion | 819.9 million |
2023-03-31 | 2.6 billion | 578.0 million |
2022-12-31 | 2.5 billion | 751.4 million |
COH.AX Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 114.4 million | ? |
2023-06-30 | 220.1 million | 15.9 million |
2023-03-31 | 121.8 million | 8.0 million |
2022-12-31 | 46.4 million | ? |
COH.AX Net Income
Date | Net Income |
---|---|
2023-12-31 | 191.4 million |
2023-06-30 | 159.0 million |
2023-03-31 | 79.5 million |
2022-12-31 | 141.6 million |
COH.AX Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 485.2 million | - | - |
2023-06-30 | 555.5 million | 162.6 million | 201.8 million |
2023-03-31 | 555.5 million | - | - |
2022-12-31 | 546.7 million | 214.0 million | - |
COH.AX Shares Outstanding
COH.AX Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 42.7 million | 127.3 million | 101.5 million | 330.5 million |
2023-06-30 | 53.2 million | 142.3 million | 110.4 million | 331.1 million |
2023-03-31 | 14.9 million | 71.2 million | 55.2 million | 165.6 million |
2022-12-31 | 42.7 million | 102.6 million | 93.5 million | 275.4 million |
COH.AX Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 1.1 billion | 285.8 million |
2023-06-30 | 1.1 billion | 261.1 million |
2023-03-31 | 525.5 million | 130.6 million |
2022-12-31 | 892.6 million | 226.9 million |
COH.AX
Price: A$319.71
Dividend Yield: 0.01%
Forward Dividend Yield: 1.21%
Payout Ratio: 75.19%
Dividend Per Share: 4.00 AUD
Earnings Per Share: 5.31 AUD
P/E Ratio: 70.60
Exchange: ASX
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 21.7 billion
Average Dividend Frequency: 2
Years Paying Dividends: 29
DGR3: 30.00%
DGR5: 22.28%
DGR10: 10.93%
DGR20: 14.05%